We have collated a list of recommendations from top brokerage firms from ETNow and other sources:
CLSA on ITC: Outperform| Target Rs 483
CLSA maintained an outperform rating on ITC with a target price of Rs 483. ITC is hosting its annual investor/analyst meet on Tuesday.
An update on the ITC Next Strategy, especially on R&D, supply chain, and digital expected
The medium-term margin aspirations for FMCG- others to be seen.
FMCG-cigarette growth outlook assuming consumption has normalized and an update on the timeline for ITC Hotels’ listing is also expected.
Goldman Sachs on Godrej Consumer: Buy| Target Rs 1185
Goldman Sachs maintained a buy rating on Godrej Consumer with a target price of Rs 1185. Multiple turnaround initiatives in varying stages of execution.
The launch of new liquid detergent holds promise.
JPMorgan on Dr Reddy’s Laboratories: Underweight| Target Rs 4610
JPMorgan maintained an underweight rating on Dr Reddy’s Laboratories with a target price of Rs 4610. Form 483 observations are likely to result in an overhang.
The US growth headwinds persist. Form 483 highlights 10 observations; 1,4 and 7 are serious. The rest of the observations range from moderate to procedural.
Morgan Stanley on Infosys: Overweight| Target Rs 1600
Morgan Stanley maintained an overweight stance on Infosys with a target price of Rs 1600. The resignation by the CFO was unanticipated and could weigh on sentiment for the stock in light of past senior exits.
We expect the transition to be a smooth one, given the role has been filled by an internal candidate.
(You can now subscribe to our ETMarkets WhatsApp channel)
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)